|
Bates White has played an important role in some of the most comprehensive and complex litigation
that has faced the health care industry in recent years. Our clients depend on us for expert
testimony, consulting and litigation support, as well as class certification, liability estimation,
and other economic analyses in connection with a full range of health care issues. Our approach
involves meticulous data analysis and statistical modeling, and our clients gain a significant
advantage from our ability to explain complex methodologies and present our conclusions in plain
language.
Our Health Care Practice consists of cross-functional teams that combine health care industry
knowledge with expertise in other areas, such as antitrust, mergers and acquisitions, product
liability, and intellectual property. Our team of academicians, economists, and experts possesses
comprehensive knowledge of institutions across the health care industry, including public and
private payors; physicians, hospitals, pharmacies, and other health care providers; pharmaceutical,
biological, and medical device manufacturers; Pharmacy Benefit Managers (PBMs), Group Purchasing
Organizations (GPOs), and other health care intermediaries; the Centers for Medicare and Medicaid
Services (CMS), Food and Drug Administration (FDA), Veteran’s Administration (VA), and other
government entities; and trade groups.
As our clients seek opportunities and respond to litigation in the evolving global health care
marketplace, they know our approaches to their challenges will be rigorous, defensible, and innovative.
Click here for a list of our services.
Events
Pricing, Innovation, & Regulation in Pharmaceutical Markets:
U.S. and European Perspectives
Articles
Will Medicaid Reform Affect
Brand-Name Manufacturers’ Choice to Market Authorized Generic
Versions of Their Drugs?
Press Releases
David Dranove,
Professor of Health Industry Management at Northwestern University’s
Kellogg School, joins Bates White as Academic Affiliate
Christopher Stomberg, Bates
White economist, assesses pharmaceutical pre-patent valuation, risks, and
hurdles at ACI forum
Cory Capps, Bates White economist,
discusses hospital-related issues at iHEA 6th World Congress
Chris Stomberg, Bates White
economist, discusses pharmaceutical bundling and price transparency at
American Conference Institute forum
Cory Capps, former
U.S. Department of Justice Antitrust Economist, joins Bates White’s
Health Care Practice
New Medicaid regulations
could force authorized generic drugs out of the market, according to
Bates White Principal Chris Stomberg
Dr.
Chris Stomberg discussed generic drug competition at Patent Life Cycles
Conference
|
